TipRanks
Go Ultimate55% OFF

RaySearch Laboratories AB (27R) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

27R Analyst Ratings

There are no analyst ratings in the last 3 months.

27R Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:27R
Price TargetFollowArticle
TipRanks - PerPlexityEUR 20.71→EUR 20.80buy14.97%UpsideReiterated11/01/26
TipRanks - GoogleEUR 19.98hold10.45%UpsideDowngraded11/01/26
TipRanks - AnthropicEUR 19.80hold9.44%UpsideReiterated11/01/26
TipRanks - OpenAIEUR 20.07hold10.95%UpsideReiterated11/01/26
TipRanks - DeepSeekEUR 19.80hold9.44%UpsideReiterated11/01/26
TipRanks - xAIEUR 19.98hold10.45%UpsideDowngraded11/01/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering RaySearch Laboratories AB

3 Months
Success Rate1/3 ratings generated profit
33%
Average Return
-13.33%

Copying PerPlexity Medical - Healthcare Information Services's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -13.33% per trade.

1 Year
Success Rate1/3 ratings generated profit
33%
Average Return
-13.33%

Copying PerPlexity Medical - Healthcare Information Services's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -13.33% per trade.

2 Years
Success Rate1/3 ratings generated profit
33%
Average Return
-13.33%

Copying PerPlexity Medical - Healthcare Information Services's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -13.33% per trade.

27R Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 27R
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 27R has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 27R average Analyst price target in the past 3 months is ―.

27R Financial Forecast

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q4 2025Q2 2026Q3 2026
HighEUR 0.23
ConsensusEUR 0.22
LowEUR 0.21

27R Earnings Forecast

Next quarter’s earnings estimate for 27R is EUR 0.22 with a range of EUR 0.21 to EUR 0.23. The previous quarter’s EPS was EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 24.7MEUR 27.6MEUR 30.5MEUR 33.4MEUR 36.2MQ4 2025Q2 2026Q3 2026
HighEUR 36.2M
ConsensusEUR 34.5M
LowEUR 32.8M

27R Sales Forecast

Next quarter’s sales forecast for 27R is EUR 34.45M with a range of EUR 32.79M to EUR 36.24M. The previous quarter’s sales results were EUR 24.73M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

27R Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about RaySearch Laboratories AB?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of RaySearch Laboratories AB?
To buy shares of DE:27R, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.